[Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension].
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000503:physiopathology; D002908:Chronic Disease; D003000:Clonidine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D012110:Reserpine / Q000627:therapeutic use*; D013997:Time Factors
D000959:Antihypertensive Agents; D004338:Drug Combinations; C005166:dihydralazine - hydrochlorothiazide - reserpine drug combination; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D003000:Clonidine
Osobennosti deĭstviia gemitona, adel'fana i dopegita na mozgovoe krovoobrashchenie pri arterial'noĭ gipertenzii.